Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA has heart

This article was originally published in The Tan Sheet

Executive Summary

Agency concludes use of heart symbol in labeling of Rexall Sundown's CoQ-10 Ultimate softgels, Twinlab's Twinsorb CoQ10 softgels is acceptable because labeling contains "contextual statements that...establish the products are not intended to treat, prevent, mitigate, diagnose or cure heart disease." In April 23 letter to law firm Arnall Golden Gregory (Atlanta), FDA notes "if a label contains adequate context to make clear that a product" is not a disease claim, then it can be considered a structure/function claim within the scope of DSHEA. Agency's letter responds to a March 18 correspondence from AGG claiming use of the heart symbol makes products unapproved new drugs...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094031

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel